BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 416439)

  • 1. Antibody-mediated activation of a defective beta-D-galactosidase: dimeric form of the activatable mutant enzyme.
    Conway de Macario E; Ellis J; Guzman R; Rotman B
    Proc Natl Acad Sci U S A; 1978 Feb; 75(2):720-4. PubMed ID: 416439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-mediated activation of genetically defective Escherichia coli beta-galactosidases by monoclonal antibodies produced by somatic cell hybrids.
    Accolla RS; Cina R; Montesoro E; Celada F
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2478-82. PubMed ID: 6787606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-mediated activation of a defective beta-D-galactosidase. II. Immunological relationship between the normal and the defective enzyme.
    Celada F; Ellis J; Bodlund K; Rotman B
    J Exp Med; 1971 Sep; 134(3 Pt 1):751-64. PubMed ID: 15776573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific inhibition of the antibody-mediated activation of a defective beta-D-galactosidase by circulating activating epitope-binding molecules.
    Conway de Macario E; Macario AJ
    J Immunol; 1979 Jul; 123(1):442-6. PubMed ID: 87481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of normal beta-D-galactosidase by antibodies to defective forms of the enzyme.
    Roth RA; Rotman B
    J Biol Chem; 1975 Oct; 250(19):7759-65. PubMed ID: 1100626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Key antigenic determinants in regulation of the immune response.
    Turkin D; Sercarz EE
    Proc Natl Acad Sci U S A; 1977 Sep; 74(9):3984-7. PubMed ID: 71736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirement of the immunogen (E. coli beta-galactosidase) for the response towards a determinant responsible for antibody-mediated enzyme activation, while antibodies binding some other site can be elicited by mitogen alone.
    Piccolella E; Centis D; Celada F
    Eur J Immunol; 1981 Apr; 11(4):286-90. PubMed ID: 6166479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional diversity of antibodies elicited by bacterial beta-D-galactosidase. Monoclonal activating, inactivating, protecting, and null antibodies to normal enzyme.
    Frackelton AR; Rotman B
    J Biol Chem; 1980 Jun; 255(11):5286-90. PubMed ID: 6768737
    [No Abstract]   [Full Text] [Related]  

  • 9. Improved procedure for the conjugation of rabbit IgG and Fab' antibodies with beta-D-galactosidase from Escherichia coli using N,N'-o-phenylenedimaleimide.
    Hamaguchi Y; Yoshitake S; Ishikawa E; Endo Y; Ohtaki S
    J Biochem; 1979 May; 85(5):1289-300. PubMed ID: 109428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta-Galactosidase: immune recognition of conformation and mechanism of antibody-induced catalytic activation.
    Celada F; Strom R
    Biopolymers; 1983 Jan; 22(1):465-73. PubMed ID: 6201205
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficient conjugation of rabbit Fab' with beta-D-galactosidase from Escherichia coli.
    Yoshitake S; Hamaguchi Y; Ishikawa E
    Scand J Immunol; 1979; 10(1):81-6. PubMed ID: 112675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constraints in T-B cooperation related to epitope topology on E. coli beta-galactosidase. I. The fine specificity of T cells dictates the fine specificity of antibodies directed to conformation-dependent determinants.
    Manca F; Kunkl A; Fenoglio D; Fowler A; Sercarz E; Celada F
    Eur J Immunol; 1985 Apr; 15(4):345-50. PubMed ID: 2580713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-mediated activation of a deletion-mutant beta-galactosidase defective in the alpha region.
    Accolla RS; Celada F
    FEBS Lett; 1976 Sep; 67(3):299-302. PubMed ID: 786724
    [No Abstract]   [Full Text] [Related]  

  • 14. An enzymatically active antigen-antibody probe to measure circulating immune complexes by competition. I. Use of Escherichia coli beta-galactosidase in the probe and of bovine conglutinin as the complex-binding reagent.
    Manca F; Migliorini P; Bombardieri S; Celada F
    Clin Immunol Immunopathol; 1980 Jun; 16(2):131-41. PubMed ID: 6769627
    [No Abstract]   [Full Text] [Related]  

  • 15. In vivo production of scFv-displaying biopolymer beads using a self-assembly-promoting fusion partner.
    Grage K; Rehm BH
    Bioconjug Chem; 2008 Jan; 19(1):254-62. PubMed ID: 18088086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of antibodies to various molecular forms of a mutationally altered Escherichia coli alkaline phosphatase on its activation by zinc.
    Pages JM; Varenne S; Lazdunski C
    Eur J Biochem; 1976 Aug; 67(1):145-53. PubMed ID: 786617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probes of beta-galactosidase structure with antibodies. Reaction of anti-peptide antibodies against native enzyme.
    Celada F; Fowler AV; Zabin I
    Biochemistry; 1978 Nov; 17(24):5156-60. PubMed ID: 103569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional properties of beta-galactosidase from mutant strain 13 PO of Escherichia coli.
    Deschavanne PJ; Viratelle OM; Yon JM
    Proc Natl Acad Sci U S A; 1978 Apr; 75(4):1892-6. PubMed ID: 25441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-mediated activation of a defective beta-D-galactosidase extracted from an Escherichia coli mutant.
    Rotman MB; Celada F
    Proc Natl Acad Sci U S A; 1968 Jun; 60(2):660-7. PubMed ID: 4882747
    [No Abstract]   [Full Text] [Related]  

  • 20. An immunological determination of specific activities of enzymes: its use in quantification of cross reactivity between enzymes of different origins.
    Guiso N; Ullmann A
    Biochimie; 1978 Sep; 60(5):467-71. PubMed ID: 100146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.